IP Library › Granted Patent US 7,747,326
Granted Patent B2
US 7,747,326 · App. 11/938,120 · Granted Jun 29, 2010

Method of treating mood disorders and/or anxiety disorders by brain stimulation

Assignee: Advanced Neuromodulation Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,747,326
App. No.
11/938,120
Granted
Jun 29, 2010
Kind
B2
Abstract

The method described herein relates to using electrical and/or chemical stimulation to treat depression or anxiety related disorders, such as obsessive compulsive disorder. More specifically, the inferior thalamic peduncle or reticular thalamic nucleus is stimulated to treat depression or anxiety related disorders.

Claims (24)

1. A method of treating a mood disorder or anxiety disorder comprising:

implanting an electrode directly into or on the inferior thalamic peduncle or reticular thalamic nucleus;

coupling the electrode to a pulse generating source; and

treating the mood disorder or anxiety disorder by generating an electrical signal with the pulse generating source wherein said signal electrically stimulates the thalamic peduncle or the reticular thalamic nucleus.

2. The method of claim 1 , wherein electrical stimulation of the inferior thalamic peduncle results in modulation of neuronal activity.

3. The method of claim 1 , wherein the mood disorder is selected from the group consisting of major depressive disorder, bipolar disorder, and dysthymic disorder.

4. The method of claim 3 , wherein the mood disorder is major depressive disorder.

5. The method of claim 1 , wherein the anxiety disorder is selected from the group consisting of panic disorder, posttraumatic stress disorder, obsessive-compulsive disorder and phobic disorder.

6. The method of claim 5 , wherein the anxiety disorder is obsessive-compulsive disorder.

7. The method of claim 1 further comprising the steps of:

surgically implanting a catheter having a proximal end coupled to a pump and a discharge portion for infusing a dosage of a pharmaceutical, wherein after implantation the discharge portion of the catheter is in direct contact with or adjacent the inferior thalamic peduncle or the reticular thalamic nucleus; and

operating the pump to discharge the pharmaceutical through the discharge portion of the catheter into the inferior thalamic peduncle thereby chemically stimulating the inferior thalamic peduncle or the reticular thalamic nucleus and treating the mood disorder or anxiety disorder.

8. The method of claim 7 , wherein the pharmaceutical is selected from the group consisting of an inhibitory neurotransmitter agonist, an excitatory neurotransmitter antagonist, an agent that increases the level of an inhibitory neurotransmitter, an agent that decrease the level of an excitatory neurotransmitter, and a local anesthetic agent.

9. The method of claim 1 , wherein electrical stimulation is applied subacutely, acutely or chronically.

10. The method of claim 1 , wherein after a period of treatment the patient is evaluated.

11. A method of treating a mood disorder or anxiety disorder comprising:

identifying a subject with a mood disorder or anxiety disorder;

implanting an electrode directly into or on a reticular thalamic nucleus or inferior thalamic peduncle;

coupling the electrode to a pulse generating source; and

treating the mood disorder or anxiety disorder by generating an electrical signal with the pulse generating source wherein said signal electrically stimulates the reticular thalamic nucleus or the inferior thalamic peduncle.

12. The method of claim 11 , wherein the mood disorder is selected from the group consisting of major depressive disorder, bipolar disorder, and dysthymic disorder.

13. The method of claim 12 , wherein the mood disorder is major depressive disorder.

14. The method of claim 11 , wherein the anxiety disorder is selected from the group consisting of panic disorder, posttraumatic stress disorder, obsessive-compulsive disorder and phobic disorder.

15. The method of claim 14 , wherein the anxiety disorder is obsessive-compulsive disorder.

Continuity (3)
Continuation 1111814000 · Apr 29, 2005
Provisional Application 6056733200 · Apr 30, 2004
Related Publication 20080125829A1 · May 29, 2008